567 related articles for article (PubMed ID: 20662087)
1. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
Xie W; Wang X; Du W; Liu W; Qin X; Huang S
Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
[TBL] [Abstract][Full Text] [Related]
2. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
[TBL] [Abstract][Full Text] [Related]
3. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
4. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
[TBL] [Abstract][Full Text] [Related]
5. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
6. [Study on the immunophenotypes of bone marrow cells from patients with myelodysplastic syndromes and its clinical implications].
Wang JY; Li XM; Li FJ; Chen XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):173-4. PubMed ID: 12513825
[TBL] [Abstract][Full Text] [Related]
7. Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.
Florian S; Sonneck K; Hauswirth AW; Krauth MT; Schernthaner GH; Sperr WR; Valent P
Leuk Lymphoma; 2006 Feb; 47(2):207-22. PubMed ID: 16321850
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
[TBL] [Abstract][Full Text] [Related]
9. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of CD34+ cell antigen expression in myelodysplastic syndromes.
De Smet D; Trullemans F; Jochmans K; Renmans W; Smet L; Heylen O; Bael AM; Schots R; Leus B; De Waele M
Am J Clin Pathol; 2012 Nov; 138(5):732-43. PubMed ID: 23086775
[TBL] [Abstract][Full Text] [Related]
11. Expressions of CD96 and CD123 in Bone Marrow Cells of Patients with Myelodysplastic Syndromes.
Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
Clin Lab; 2015; 61(10):1429-34. PubMed ID: 26642704
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
[TBL] [Abstract][Full Text] [Related]
13. [Four-color flow cytometric immunophenotypic features of blasts in myelodysplastic syndromes].
Wu YJ; Li JY; Qiu HR; Xiao B; Zhang JF; Song JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):50-3. PubMed ID: 16584591
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications.
Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Zheng Y; Qian L; Yang T; Yang C; Feng B
Chin Med J (Engl); 1998 Jan; 111(1):28-31. PubMed ID: 10322648
[TBL] [Abstract][Full Text] [Related]
15. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
[TBL] [Abstract][Full Text] [Related]
16. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
[TBL] [Abstract][Full Text] [Related]
17. Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes.
Sandes AF; Kerbauy DM; Matarraz S; Chauffaille Mde L; López A; Orfao A; Yamamoto M
Cytometry B Clin Cytom; 2013 May; 84(3):157-66. PubMed ID: 23475532
[TBL] [Abstract][Full Text] [Related]
18. Increased CD34+CD38 -CD123 + cells in myelodysplastic syndrome displaying malignant features similar to those in AML.
Li LJ; Tao JL; Fu R; Wang HQ; Jiang HJ; Yue LZ; Zhang W; Liu H; Shao ZH
Int J Hematol; 2014 Jul; 100(1):60-9. PubMed ID: 24846193
[TBL] [Abstract][Full Text] [Related]
19. [Expression of CD133 in the bone marrow of patients with myelodysplastic syndrome and its clinical significance].
Zhong LY; DU X; Geng SX; Weng JY; Zheng HT; Wu SJ; Li YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):854-5. PubMed ID: 21602141
[TBL] [Abstract][Full Text] [Related]
20. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
